PHI with Altered plasma viscosity
How does this condition affect your private health insurance?
Plasma viscosity change refers to an alteration in the resistance to flow of blood plasma, primarily influenced by protein concentrations like fibrinogen and immunoglobulins. Elevated viscosity can impede microcirculation, potentially leading to reduced oxygen delivery to tissues. It is not typically a primary disease but a marker or consequence of underlying conditions such as inflammatory diseases, autoimmune disorders, certain cancers (e.g., multiple myeloma, Waldenström's macroglobulinemia), or severe dehydration. Symptoms can include headaches, visual disturbances, dizziness, or, in severe cases, hyperviscosity syndrome, increasing risks of thrombosis, stroke, and organ damage. Management focuses on treating the root cause.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 10%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms related to acute changes in plasma viscosity, or the initial diagnostic period, typically last days to several weeks. The underlying cause may have been present longer or recently manifested.
Duration of Illness (Lifetime)
Often chronic or recurrent. Since it is frequently secondary to chronic diseases (e.g., autoimmune conditions, hematological malignancies), altered plasma viscosity may persist or recur over a patient's lifetime.
Cost of Treatment (Initial)
Several hundred to several thousand Euros for diagnosis (blood tests, specialist consultations, imaging) and initial management. Costs can be significantly higher if hospitalization or emergency treatments like plasmapheresis are required.
Cost of Treatment (Lifetime)
Highly variable, ranging from thousands for managing recurrent acute episodes to tens or hundreds of thousands of Euros over a lifetime for chronic underlying conditions requiring ongoing monitoring, medication, and specialized therapies such as regular plasmapheresis.
Mortality Rate
Low directly due to viscosity changes if managed appropriately. However, the severe underlying diseases causing it (e.g., certain cancers) can have high mortality rates, ranging from 10% to over 50% depending on the specific condition and stage.
Risk of Secondary Damages
Moderate to high (e.g., 30-70%). Impaired microcirculation can lead to significant secondary damage, including neurological deficits (e.g., stroke, headaches, visual disturbances), cardiovascular complications (e.g., thrombosis, heart failure), renal impairment, and peripheral ischemia.
Probability of Full Recovery
Moderate (e.g., 40-60%) if the underlying cause is acute, transient, and treatable (e.g., acute inflammation, dehydration). Probability of complete recovery is low (e.g., 10-30%) if due to chronic, incurable conditions such as advanced multiple myeloma or Waldenström's macroglobulinemia.
Underlying Disease Risk
Very high (>90%). Altered plasma viscosity is almost always a secondary phenomenon, acting as a marker or consequence of another medical condition rather than being a standalone primary disease.